BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

Go back to BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
(NASDAQ: BTAI) Delayed: 0.18 -0.54 (75%)
Previous Close $0.72    52 Week High
Open $0.22    52 Week Low
Day High $0.23    P/E N/A 
Day Low $0.16    EPS
Volume 57,347,701